Brief: Sight Sciences Says Evaluating Guidance For FY 2023 Due To Uncertain Impact Of Reimbursement Coverage For Its Surgical Glaucoma Segment

Sight Sciences

26/10/2023 23:31

Oct 26 (Reuters) - Sight Sciences Inc  SGHT.O :
    * SIGHT SCIENCES INC - EVALUATING GUIDANCE FOR FY 2023 DUE
TO
UNCERTAIN IMPACT OF REIMBURSEMENT COVERAGE FOR ITS SURGICAL
GLAUCOMA SEGMENT
    * SIGHT SCIENCES: ASSESSING LCD’S GONIOTOMY COVERAGE
DETERMINATIONS & POTENTIAL IMPACT ON CONTINUED COVERAGE FOR SION
SURGICAL INSTRUMENT TECHNOLOGY
    * SIGHT SCIENCES INC - WPS-SERVED STATES ACCOUNTED FOR
APPROXIMATELY 8% OF THE COMPANY’S SURGICAL GLAUCOMA REVENUE IN
2022
    * SIGHT SCIENCES INC - PLANS TO CONTINUE TO ENGAGE WITH WPS
AND
THE OTHER MACS TO MAINTAIN COVERAGE FOR OMNI

Source text for Eikon:  ID: 
Further company coverage:  SGHT.O 

 ((Reuters.Briefs@thomsonreuters.com;))